Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells

Endocrinology

Volumn 142, Issue 1, 2001, Pages 121-128

  Charland, S ^a   Boucher, M J ^a   Houde, M ^a   Rivard, N ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CERULETIDE; MITOGEN ACTIVATED PROTEIN KINASE; OCTREOTIDE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN P44; RECEPTOR SUBTYPE; SOMATOSTATIN;

ACINAR CELL; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; DNA CONTENT; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH INHIBITION; MOLECULAR CLONING; NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR AFFINITY; TUMOR GROWTH;

EID: 0035111692     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.1.7908     Document Type: Article

References (75)

1. Differentiation and development of the pancreas in animals
2. Negative control by sandostatin on pancreatic and duodenal growth: A possible implication of insulin-like growth factor I
3. Regulation of pancreatic tyrosine kinase and phosphatase activities by cholecystokinin and somatostatin
4. Mechanisms of antineoplastic action of somatostatin analogs
5. Agonists and antagonists of regulatory peptides as tools to study regulation of pancreatic exocrine secretion, cell proliferation and gene expression
6. Bombesin-induced pancreatic regeneration in pigs is mediated by p46Shc/p52Shc and p42/p44 mitogen-activated protein kinase up-regulation
7. Effects of calcium mediated secretagogues on the growth of the pancreatic acinar cells in vitro
8. Somatostatin suppresses secretin and pancreatic exocrine secretion
9. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumor growth
10. Oncological applications of somatostatm analogues
11. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: A primary role for tyrosine phosphatase SHP-1
12. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase
13. G protein activation of a hormone-stimulated phosphatase in human tumor cells
14. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism
15. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
16. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
17. Molecular biology of somatostatin receptor subtypes
18. Molecular biology of somatostatin receptors
19. Somatostatin receptor subtypes: Specific expression and signalling properties
20. Molecular pharmacology of somatostatin-receptor subtypes
21. SST2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1
22. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling
23. Somatostatin-14 andits analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block
24. Inhibition of human breast cancer cells (MCF-7) growth in vitro by the somatostatin analog SMS 201-995: Effects on cell cycle parameters and apoptotic cell death
25. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3
26. Mammalian G1 cyclins
27. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation
28. Inhibitors of mammalian G1 cyclin-dependent kinases
29. Pancreatic digestive enzyme gene expression: Effect of CCK and soybean trypsin inhibitor
30. Effects of SMS 201-995 in basal and stimulated pancreatic secretion in rats
31. A simplification of the protein assay method of Lowry et al. which is more generally applicable
32. Cell signalling pathways involved in Pacap-induced AR4-2J cell proliferation
33. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts
34. Co-purification of a protein tyrosine phosphatase with activated somatostatin receptor from rat pancreatic acinar cells
35. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation
36. Phosphatidylinositol 3-kinase
37. Cellular survivah a play in three Akts
38. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
39. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms
40. Kip1) of cyclin-dependent kinase 4 activation
41. The interaction of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase
42. TGF beta inhibition of cdk4 synthesis is linked to cell cycle arrest
43. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
44. Different roles for cyclins D1 and E in regulation of the G1-to-S transition
45. Rescue of defective mitogenic signaling by D-type cyclins
46. Molecular biology of somatostatm receptors
47. Somatostatin receptor activation of cellular effector systems
48. Expression of mRNA for all five human somatostatin receptors (hSST R1-5) in pituitary tumors
49. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines
50. Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin
51. Molecular mechanisms of antiprollferative effect of somatostatin: Involvement of a tyrosine phosphatase
52. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
53. Hematopoietic cell phosphatase associates with the interleukin-3 (Il-3) receptor beta chain and down-regulates Il-3-induced tyrosine phosphorylation and mitogenesis
54. kip1evidence for the role of SHP-1
55. Kip1 Endocrinology
56. TGFβ and cAMP inhibit proliferation of PANC-1, a human pancreatic cancer cell line, by different molecular mechanisms
57. Somatostatin inhibition of phosphoinositides turnover in isolated rat acinar pancreatic cells: Interaction with bombesin
58. Somatostatin inhibits vasopressin-stimulated phosphoinositide hydrolysis and influx of extracellular calcium in clonal hamster beta (HIT) cells
59. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase
60. Apopam/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
61. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells
62. A temporal and biochemical link between growth factor-activated MAP kinases cyclin D1 induction and cell cycle entry
63. kip1 by cDNA antisense suppresses quiescence (GO state) in fibroblasts
64. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
65. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest
66. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin
67. Kip1 for restriction point control of the fibroblast cell cycle
68. Enhanced growth of mice lacking the cyclin-dependent kmase inhibitor function of p27(Kip1)
69. Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(Kip1) independent of MAPK activity
70. Aging impairs induction of cyclin-dependent kinases and down-regulation of p27 in mouse CD4(+) cells
71. kip1
72. C-terminal region of human somatostatin receptor 5 for induction of Rb and G1 cell cycle arrest
73. Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)
74. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
75. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer